You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 21, 2024

DARAPRIM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Daraprim patents expire, and what generic alternatives are available?

Daraprim is a drug marketed by Tilde Sciences and is included in one NDA.

The generic ingredient in DARAPRIM is pyrimethamine. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pyrimethamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Daraprim

A generic version of DARAPRIM was approved as pyrimethamine by CEROVENE INC on February 28th, 2020.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DARAPRIM?
  • What are the global sales for DARAPRIM?
  • What is Average Wholesale Price for DARAPRIM?
Drug patent expirations by year for DARAPRIM
Drug Prices for DARAPRIM

See drug prices for DARAPRIM

Recent Clinical Trials for DARAPRIM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Washington University School of MedicineEarly Phase 1
Montefiore Medical CenterPhase 1
Albert Einstein College of MedicinePhase 1

See all DARAPRIM clinical trials

Pharmacology for DARAPRIM

US Patents and Regulatory Information for DARAPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tilde Sciences DARAPRIM pyrimethamine TABLET;ORAL 008578-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.